Global Cognition-Enhancing Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cognition-Enhancing Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Cognition-Enhancing Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Cognition-Enhancing Drugs by Country/Region, 2017, 2022 & 2028

2.2 Cognition-Enhancing Drugs Segment by Type

2.2.1 Oral

2.2.2 Injection

2.3 Cognition-Enhancing Drugs Sales by Type

2.3.1 Global Cognition-Enhancing Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Cognition-Enhancing Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Cognition-Enhancing Drugs Sale Price by Type (2017-2022)

2.4 Cognition-Enhancing Drugs Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Drug Stores

2.4.3 Retail Pharmacies

2.5 Cognition-Enhancing Drugs Sales by Application

2.5.1 Global Cognition-Enhancing Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Cognition-Enhancing Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Cognition-Enhancing Drugs Sale Price by Application (2017-2022)

3 Global Cognition-Enhancing Drugs by Company

3.1 Global Cognition-Enhancing Drugs Breakdown Data by Company

3.1.1 Global Cognition-Enhancing Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Cognition-Enhancing Drugs Sales Market Share by Company (2020-2022)

3.2 Global Cognition-Enhancing Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Cognition-Enhancing Drugs Revenue by Company (2020-2022)

3.2.2 Global Cognition-Enhancing Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Cognition-Enhancing Drugs Sale Price by Company

3.4 Key Manufacturers Cognition-Enhancing Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Cognition-Enhancing Drugs Product Location Distribution

3.4.2 Players Cognition-Enhancing Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Cognition-Enhancing Drugs by Geographic Region

4.1 World Historic Cognition-Enhancing Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Cognition-Enhancing Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Cognition-Enhancing Drugs Annual Revenue by Geographic Region

4.2 World Historic Cognition-Enhancing Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Cognition-Enhancing Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Cognition-Enhancing Drugs Annual Revenue by Country/Region

4.3 Americas Cognition-Enhancing Drugs Sales Growth

4.4 APAC Cognition-Enhancing Drugs Sales Growth

4.5 Europe Cognition-Enhancing Drugs Sales Growth

4.6 Middle East & Africa Cognition-Enhancing Drugs Sales Growth

5 Americas

5.1 Americas Cognition-Enhancing Drugs Sales by Country

5.1.1 Americas Cognition-Enhancing Drugs Sales by Country (2017-2022)

5.1.2 Americas Cognition-Enhancing Drugs Revenue by Country (2017-2022)

5.2 Americas Cognition-Enhancing Drugs Sales by Type

5.3 Americas Cognition-Enhancing Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cognition-Enhancing Drugs Sales by Region

6.1.1 APAC Cognition-Enhancing Drugs Sales by Region (2017-2022)

6.1.2 APAC Cognition-Enhancing Drugs Revenue by Region (2017-2022)

6.2 APAC Cognition-Enhancing Drugs Sales by Type

6.3 APAC Cognition-Enhancing Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Cognition-Enhancing Drugs by Country

7.1.1 Europe Cognition-Enhancing Drugs Sales by Country (2017-2022)

7.1.2 Europe Cognition-Enhancing Drugs Revenue by Country (2017-2022)

7.2 Europe Cognition-Enhancing Drugs Sales by Type

7.3 Europe Cognition-Enhancing Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cognition-Enhancing Drugs by Country

8.1.1 Middle East & Africa Cognition-Enhancing Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Cognition-Enhancing Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Cognition-Enhancing Drugs Sales by Type

8.3 Middle East & Africa Cognition-Enhancing Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Cognition-Enhancing Drugs

10.3 Manufacturing Process Analysis of Cognition-Enhancing Drugs

10.4 Industry Chain Structure of Cognition-Enhancing Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Cognition-Enhancing Drugs Distributors

11.3 Cognition-Enhancing Drugs Customer

12 World Forecast Review for Cognition-Enhancing Drugs by Geographic Region

12.1 Global Cognition-Enhancing Drugs Market Size Forecast by Region

12.1.1 Global Cognition-Enhancing Drugs Forecast by Region (2023-2028)

12.1.2 Global Cognition-Enhancing Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Cognition-Enhancing Drugs Forecast by Type

12.7 Global Cognition-Enhancing Drugs Forecast by Application

13 Key Players Analysis

13.1 Accelerated Intelligence

13.1.1 Accelerated Intelligence Company Information

13.1.2 Accelerated Intelligence Cognition-Enhancing Drugs Product Offered

13.1.3 Accelerated Intelligence Cognition-Enhancing Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Accelerated Intelligence Main Business Overview

13.1.5 Accelerated Intelligence Latest Developments

13.2 Cognition Therapeutics

13.2.1 Cognition Therapeutics Company Information

13.2.2 Cognition Therapeutics Cognition-Enhancing Drugs Product Offered

13.2.3 Cognition Therapeutics Cognition-Enhancing Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Cognition Therapeutics Main Business Overview

13.2.5 Cognition Therapeutics Latest Developments

13.3 Cogstate

13.3.1 Cogstate Company Information

13.3.2 Cogstate Cognition-Enhancing Drugs Product Offered

13.3.3 Cogstate Cognition-Enhancing Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Cogstate Main Business Overview

13.3.5 Cogstate Latest Developments

13.4 HVMN

13.4.1 HVMN Company Information

13.4.2 HVMN Cognition-Enhancing Drugs Product Offered

13.4.3 HVMN Cognition-Enhancing Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 HVMN Main Business Overview

13.4.5 HVMN Latest Developments

13.5 Biogen Idec

13.5.1 Biogen Idec Company Information

13.5.2 Biogen Idec Cognition-Enhancing Drugs Product Offered

13.5.3 Biogen Idec Cognition-Enhancing Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Biogen Idec Main Business Overview

13.5.5 Biogen Idec Latest Developments

14 Research Findings and Conclusion

Table 1. Cognition-Enhancing Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Cognition-Enhancing Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oral

Table 4. Major Players of Injection

Table 5. Global Cognition-Enhancing Drugs Sales by Type (2017-2022) & (K MT)

Table 6. Global Cognition-Enhancing Drugs Sales Market Share by Type (2017-2022)

Table 7. Global Cognition-Enhancing Drugs Revenue by Type (2017-2022) & ($ million)

Table 8. Global Cognition-Enhancing Drugs Revenue Market Share by Type (2017-2022)

Table 9. Global Cognition-Enhancing Drugs Sale Price by Type (2017-2022) & (USD/MT)

Table 10. Global Cognition-Enhancing Drugs Sales by Application (2017-2022) & (K MT)

Table 11. Global Cognition-Enhancing Drugs Sales Market Share by Application (2017-2022)

Table 12. Global Cognition-Enhancing Drugs Revenue by Application (2017-2022)

Table 13. Global Cognition-Enhancing Drugs Revenue Market Share by Application (2017-2022)

Table 14. Global Cognition-Enhancing Drugs Sale Price by Application (2017-2022) & (USD/MT)

Table 15. Global Cognition-Enhancing Drugs Sales by Company (2020-2022) & (K MT)

Table 16. Global Cognition-Enhancing Drugs Sales Market Share by Company (2020-2022)

Table 17. Global Cognition-Enhancing Drugs Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Cognition-Enhancing Drugs Revenue Market Share by Company (2020-2022)

Table 19. Global Cognition-Enhancing Drugs Sale Price by Company (2020-2022) & (USD/MT)

Table 20. Key Manufacturers Cognition-Enhancing Drugs Producing Area Distribution and Sales Area

Table 21. Players Cognition-Enhancing Drugs Products Offered

Table 22. Cognition-Enhancing Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Cognition-Enhancing Drugs Sales by Geographic Region (2017-2022) & (K MT)

Table 26. Global Cognition-Enhancing Drugs Sales Market Share Geographic Region (2017-2022)

Table 27. Global Cognition-Enhancing Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Cognition-Enhancing Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Cognition-Enhancing Drugs Sales by Country/Region (2017-2022) & (K MT)

Table 30. Global Cognition-Enhancing Drugs Sales Market Share by Country/Region (2017-2022)

Table 31. Global Cognition-Enhancing Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Cognition-Enhancing Drugs Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Cognition-Enhancing Drugs Sales by Country (2017-2022) & (K MT)

Table 34. Americas Cognition-Enhancing Drugs Sales Market Share by Country (2017-2022)

Table 35. Americas Cognition-Enhancing Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Cognition-Enhancing Drugs Revenue Market Share by Country (2017-2022)

Table 37. Americas Cognition-Enhancing Drugs Sales by Type (2017-2022) & (K MT)

Table 38. Americas Cognition-Enhancing Drugs Sales Market Share by Type (2017-2022)

Table 39. Americas Cognition-Enhancing Drugs Sales by Application (2017-2022) & (K MT)

Table 40. Americas Cognition-Enhancing Drugs Sales Market Share by Application (2017-2022)

Table 41. APAC Cognition-Enhancing Drugs Sales by Region (2017-2022) & (K MT)

Table 42. APAC Cognition-Enhancing Drugs Sales Market Share by Region (2017-2022)

Table 43. APAC Cognition-Enhancing Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Cognition-Enhancing Drugs Revenue Market Share by Region (2017-2022)

Table 45. APAC Cognition-Enhancing Drugs Sales by Type (2017-2022) & (K MT)

Table 46. APAC Cognition-Enhancing Drugs Sales Market Share by Type (2017-2022)

Table 47. APAC Cognition-Enhancing Drugs Sales by Application (2017-2022) & (K MT)

Table 48. APAC Cognition-Enhancing Drugs Sales Market Share by Application (2017-2022)

Table 49. Europe Cognition-Enhancing Drugs Sales by Country (2017-2022) & (K MT)

Table 50. Europe Cognition-Enhancing Drugs Sales Market Share by Country (2017-2022)

Table 51. Europe Cognition-Enhancing Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Cognition-Enhancing Drugs Revenue Market Share by Country (2017-2022)

Table 53. Europe Cognition-Enhancing Drugs Sales by Type (2017-2022) & (K MT)

Table 54. Europe Cognition-Enhancing Drugs Sales Market Share by Type (2017-2022)

Table 55. Europe Cognition-Enhancing Drugs Sales by Application (2017-2022) & (K MT)

Table 56. Europe Cognition-Enhancing Drugs Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Cognition-Enhancing Drugs Sales by Country (2017-2022) & (K MT)

Table 58. Middle East & Africa Cognition-Enhancing Drugs Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Cognition-Enhancing Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Cognition-Enhancing Drugs Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Cognition-Enhancing Drugs Sales by Type (2017-2022) & (K MT)

Table 62. Middle East & Africa Cognition-Enhancing Drugs Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Cognition-Enhancing Drugs Sales by Application (2017-2022) & (K MT)

Table 64. Middle East & Africa Cognition-Enhancing Drugs Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Cognition-Enhancing Drugs

Table 66. Key Market Challenges & Risks of Cognition-Enhancing Drugs

Table 67. Key Industry Trends of Cognition-Enhancing Drugs

Table 68. Cognition-Enhancing Drugs Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Cognition-Enhancing Drugs Distributors List

Table 71. Cognition-Enhancing Drugs Customer List

Table 72. Global Cognition-Enhancing Drugs Sales Forecast by Region (2023-2028) & (K MT)

Table 73. Global Cognition-Enhancing Drugs Sales Market Forecast by Region

Table 74. Global Cognition-Enhancing Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Cognition-Enhancing Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Cognition-Enhancing Drugs Sales Forecast by Country (2023-2028) & (K MT)

Table 77. Americas Cognition-Enhancing Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Cognition-Enhancing Drugs Sales Forecast by Region (2023-2028) & (K MT)

Table 79. APAC Cognition-Enhancing Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Cognition-Enhancing Drugs Sales Forecast by Country (2023-2028) & (K MT)

Table 81. Europe Cognition-Enhancing Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Cognition-Enhancing Drugs Sales Forecast by Country (2023-2028) & (K MT)

Table 83. Middle East & Africa Cognition-Enhancing Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Cognition-Enhancing Drugs Sales Forecast by Type (2023-2028) & (K MT)

Table 85. Global Cognition-Enhancing Drugs Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Cognition-Enhancing Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Cognition-Enhancing Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Cognition-Enhancing Drugs Sales Forecast by Application (2023-2028) & (K MT)

Table 89. Global Cognition-Enhancing Drugs Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Cognition-Enhancing Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Cognition-Enhancing Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 92. Accelerated Intelligence Basic Information, Cognition-Enhancing Drugs Manufacturing Base, Sales Area and Its Competitors

Table 93. Accelerated Intelligence Cognition-Enhancing Drugs Product Offered

Table 94. Accelerated Intelligence Cognition-Enhancing Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 95. Accelerated Intelligence Main Business

Table 96. Accelerated Intelligence Latest Developments

Table 97. Cognition Therapeutics Basic Information, Cognition-Enhancing Drugs Manufacturing Base, Sales Area and Its Competitors

Table 98. Cognition Therapeutics Cognition-Enhancing Drugs Product Offered

Table 99. Cognition Therapeutics Cognition-Enhancing Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 100. Cognition Therapeutics Main Business

Table 101. Cognition Therapeutics Latest Developments

Table 102. Cogstate Basic Information, Cognition-Enhancing Drugs Manufacturing Base, Sales Area and Its Competitors

Table 103. Cogstate Cognition-Enhancing Drugs Product Offered

Table 104. Cogstate Cognition-Enhancing Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 105. Cogstate Main Business

Table 106. Cogstate Latest Developments

Table 107. HVMN Basic Information, Cognition-Enhancing Drugs Manufacturing Base, Sales Area and Its Competitors

Table 108. HVMN Cognition-Enhancing Drugs Product Offered

Table 109. HVMN Cognition-Enhancing Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 110. HVMN Main Business

Table 111. HVMN Latest Developments

Table 112. Biogen Idec Basic Information, Cognition-Enhancing Drugs Manufacturing Base, Sales Area and Its Competitors

Table 113. Biogen Idec Cognition-Enhancing Drugs Product Offered

Table 114. Biogen Idec Cognition-Enhancing Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 115. Biogen Idec Main Business

Table 116. Biogen Idec Latest Developments

List of Figures

Figure 1. Picture of Cognition-Enhancing Drugs

Figure 2. Cognition-Enhancing Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Cognition-Enhancing Drugs Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Cognition-Enhancing Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Cognition-Enhancing Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oral

Figure 10. Product Picture of Injection

Figure 11. Global Cognition-Enhancing Drugs Sales Market Share by Type in 2021

Figure 12. Global Cognition-Enhancing Drugs Revenue Market Share by Type (2017-2022)

Figure 13. Cognition-Enhancing Drugs Consumed in Hospital Pharmacies

Figure 14. Global Cognition-Enhancing Drugs Market: Hospital Pharmacies (2017-2022) & (K MT)

Figure 15. Cognition-Enhancing Drugs Consumed in Drug Stores

Figure 16. Global Cognition-Enhancing Drugs Market: Drug Stores (2017-2022) & (K MT)

Figure 17. Cognition-Enhancing Drugs Consumed in Retail Pharmacies

Figure 18. Global Cognition-Enhancing Drugs Market: Retail Pharmacies (2017-2022) & (K MT)

Figure 19. Global Cognition-Enhancing Drugs Sales Market Share by Application (2017-2022)

Figure 20. Global Cognition-Enhancing Drugs Revenue Market Share by Application in 2021

Figure 21. Cognition-Enhancing Drugs Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Cognition-Enhancing Drugs Revenue Market Share by Company in 2021

Figure 23. Global Cognition-Enhancing Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Cognition-Enhancing Drugs Revenue Market Share by Geographic Region in 2021

Figure 25. Global Cognition-Enhancing Drugs Sales Market Share by Region (2017-2022)

Figure 26. Global Cognition-Enhancing Drugs Revenue Market Share by Country/Region in 2021

Figure 27. Americas Cognition-Enhancing Drugs Sales 2017-2022 (K MT)

Figure 28. Americas Cognition-Enhancing Drugs Revenue 2017-2022 ($ Millions)

Figure 29. APAC Cognition-Enhancing Drugs Sales 2017-2022 (K MT)

Figure 30. APAC Cognition-Enhancing Drugs Revenue 2017-2022 ($ Millions)

Figure 31. Europe Cognition-Enhancing Drugs Sales 2017-2022 (K MT)

Figure 32. Europe Cognition-Enhancing Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Cognition-Enhancing Drugs Sales 2017-2022 (K MT)

Figure 34. Middle East & Africa Cognition-Enhancing Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Americas Cognition-Enhancing Drugs Sales Market Share by Country in 2021

Figure 36. Americas Cognition-Enhancing Drugs Revenue Market Share by Country in 2021

Figure 37. United States Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Cognition-Enhancing Drugs Sales Market Share by Region in 2021

Figure 42. APAC Cognition-Enhancing Drugs Revenue Market Share by Regions in 2021

Figure 43. China Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Cognition-Enhancing Drugs Sales Market Share by Country in 2021

Figure 50. Europe Cognition-Enhancing Drugs Revenue Market Share by Country in 2021

Figure 51. Germany Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Cognition-Enhancing Drugs Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Cognition-Enhancing Drugs Revenue Market Share by Country in 2021

Figure 58. Egypt Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Cognition-Enhancing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Cognition-Enhancing Drugs in 2021

Figure 64. Manufacturing Process Analysis of Cognition-Enhancing Drugs

Figure 65. Industry Chain Structure of Cognition-Enhancing Drugs

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles